0000950170-24-044853.txt : 20240416 0000950170-24-044853.hdr.sgml : 20240416 20240416170422 ACCESSION NUMBER: 0000950170-24-044853 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240414 FILED AS OF DATE: 20240416 DATE AS OF CHANGE: 20240416 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Iadonato Shawn CENTRAL INDEX KEY: 0001958184 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37695 FILM NUMBER: 24848587 MAIL ADDRESS: STREET 1: C/O KINETA, INC. STREET 2: 219 TERRY AVE. N., SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KINETA, INC./DE CENTRAL INDEX KEY: 0001445283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7683 SE 27TH STREET STREET 2: SUITE 481 CITY: MERCER ISLAND STATE: WA ZIP: 98040 BUSINESS PHONE: (206) 378-0400 MAIL ADDRESS: STREET 1: 7683 SE 27TH STREET STREET 2: SUITE 481 CITY: MERCER ISLAND STATE: WA ZIP: 98040 FORMER COMPANY: FORMER CONFORMED NAME: YUMANITY THERAPEUTICS, INC. DATE OF NAME CHANGE: 20201223 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140813 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC DATE OF NAME CHANGE: 20080916 4 1 ownership.xml 4 X0508 4 2024-04-14 0001445283 KINETA, INC./DE KA 0001958184 Iadonato Shawn C/O KINETA, INC. 7683 SE 27TH STREET, SUITE 481 MERCER ISLAND WA 98040 true false false false false Stock Option (Right to Buy) 0.36 2024-04-14 4 A false 225000 0 A 2034-04-13 Common Stock 225000 225000 D 25% of the shares are vested and exercisable upon the grant, 25% of the shares will vest and become exercisable over the 36 month period following the award on the one-month anniversary of the vesting commencement date subject to the reporting person's continuous service status through each vesting date, and 50% of the shares will vest and become exercisable subject to the achievement of a Transaction or Qualified Transaction. Footnote 2 is a continuation of Footnote 1: A "Qualified Transaction" is defined as either (i) a capital raise commitment of greater than $25 million with a minimum of $10 million upon closing or (ii) a partnership event resulting in an upfront cash payment to the Company of at least $15 million with future milestones of greater than $100 million (in cash and equity). In the event the Board of Directors of the Company approves a transaction that does not meet the criteria of a Qualified Transaction, it shall be deemed a "Transaction". In the event of the Qualified Transaction, all such shares shall immediately become fully vested and exercisable. In the event of a Transaction, all shares shall vest in an equal monthly number such that the shares will be vested and exercisable in full 36 months following the award date. /s/ Shawn Iadonato 2024-04-16